28.10.2019 14:05:00
|
KORU Medical Systems Schedules 2019 Third Quarter Financial Results and Conference Call
Repro Med Systems, Inc. dba KORU Medical Systems (NASDAQ: KRMD) today announced that it will release its financial results for the third quarter and nine months ended September 30, 2019 after the close of the financial markets on Tuesday, November 5, 2019. Management will host a conference call on Wednesday, November 6, 2019 at 9:00 am ET to discuss the results and business activities.
Interested parties may participate in the call by dialing:
- (877) 407-9753 (Domestic) or
- (201) 493-6739 (International)
Webcast registration: Click Here
Following the live call, a replay will be available for six months on the Company's website, www.korumedical.com under "Investor Relations."
About KORU Medical Systems
KORU Medical Systems develops, manufactures and commercializes innovative and easy-to-use specialty infusion solutions that improve quality of life for patients around the world. The FREEDOM Syringe Infusion System currently includes the FREEDOM60® and FreedomEdge® Syringe Infusion Drivers, Precision Flow Rate Tubing™ and HIgH-Flo Subcutaneous Safety Needle Sets™. These devices are used for infusions administered in the home and alternate care settings. For more information, please visit www.korumedical.com.
Forward-Looking Statements
The statements contained herein include prospects, statements of future expectations and other forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 that are based on management's current views and assumptions and involve known and unknown risks and uncertainties, identified by words such as "will”. Actual results, performance or events may differ materially from those expressed or implied in such forward-looking statements. Factors that may cause actual results to differ materially from current expectations and other risks are discussed in the Company’s filings with the U.S. Securities and Exchange Commission, including its Annual Report on Form 10-K, which filings are available from the SEC and the Company’s website. The Company undertakes no obligation to update any forward-looking statements.
View source version on businesswire.com: https://www.businesswire.com/news/home/20191028005456/en/
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Repro Medical System IncShsmehr Nachrichten
12.11.24 |
Ausblick: Repro Medical System stellt Zahlen zum jüngsten Quartal vor (finanzen.net) | |
29.10.24 |
Erste Schätzungen: Repro Medical System vermeldet Zahlen zum jüngsten Quartal (finanzen.net) | |
06.08.24 |
Ausblick: Repro Medical System stellt das Zahlenwerk zum vergangenen Quartal vor (finanzen.net) | |
23.07.24 |
Erste Schätzungen: Repro Medical System verkündet Quartalsergebnis zum jüngsten Jahresviertel (finanzen.net) |